Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Oba

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Clinical Nephrology|February 8, 2024
Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case reportYusuke Yoshimura, Tatsuya Suwabe, Arisa Fujiki, et al.
Oncology Letters|August 5, 2024
Renal cell carcinoma preceded by a rheumatoid‑like paraneoplastic syndrome: A case reportYusuke Yoshimura, Tatsuya Suwabe, Katsuyuki Miki, et al.
CEN Case Reports|January 20, 2025
A case of mucormycosis caused by Rhizopus microsporus in a renal transplant patientMiruzato Fukuda, Takayoshi Yokoyama, Morota Marie, et al.
Clinical Kidney Journal|July 10, 2024
Long-term clinicopathological characteristics of TAFRO syndrome and its relapse: a case series studyYusuke Yoshimura, Hiroki Mizuno, Daisuke Ikuma, et al.
CEN Case Reports|March 23, 2024
De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney diseaseMiruzato Fukuda, Takayoshi Yokoyama, Katsuyuki Miki, et al.
CEN Case Reports|April 18, 2026
A case of giant renal angiomyolipoma and diabetic nephropathy with abnormalities in the genes TSC2 and HNF1BHisashi Sugimoto, Naoki Sawa, Yuki Oba, et al.
Rheumatology (Oxford, England)|January 25, 2025
Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney diseaseYusuke Yoshimura, Masayuki Yamanouchi, Ryo Koizumi, et al.
Scientific Reports|May 17, 2017
A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β<sub>1</sub> pathwaysHisato Shima, Kensuke Sasaki, Takehiro Suzuki, et al.
The Tohoku Journal of Experimental Medicine|June 30, 2015
Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial DiseasesTakehiro Suzuki, Hiroaki Yamaguchi, Motoi Kikusato, et al.
BMJ Open Diabetes Research & Care|August 13, 2021
Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney diseaseMasayuki Yamanouchi, Kengo Furuichi, Junichi Hoshino, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Clinical Nephrology|February 8, 2024
Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case reportYusuke Yoshimura, Tatsuya Suwabe, Arisa Fujiki, et al.
Oncology Letters|August 5, 2024
Renal cell carcinoma preceded by a rheumatoid‑like paraneoplastic syndrome: A case reportYusuke Yoshimura, Tatsuya Suwabe, Katsuyuki Miki, et al.
CEN Case Reports|January 20, 2025
A case of mucormycosis caused by Rhizopus microsporus in a renal transplant patientMiruzato Fukuda, Takayoshi Yokoyama, Morota Marie, et al.
Clinical Kidney Journal|July 10, 2024
Long-term clinicopathological characteristics of TAFRO syndrome and its relapse: a case series studyYusuke Yoshimura, Hiroki Mizuno, Daisuke Ikuma, et al.
CEN Case Reports|March 23, 2024
De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney diseaseMiruzato Fukuda, Takayoshi Yokoyama, Katsuyuki Miki, et al.
CEN Case Reports|April 18, 2026
A case of giant renal angiomyolipoma and diabetic nephropathy with abnormalities in the genes TSC2 and HNF1BHisashi Sugimoto, Naoki Sawa, Yuki Oba, et al.
Rheumatology (Oxford, England)|January 25, 2025
Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney diseaseYusuke Yoshimura, Masayuki Yamanouchi, Ryo Koizumi, et al.
Scientific Reports|May 17, 2017
A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β<sub>1</sub> pathwaysHisato Shima, Kensuke Sasaki, Takehiro Suzuki, et al.
The Tohoku Journal of Experimental Medicine|June 30, 2015
Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial DiseasesTakehiro Suzuki, Hiroaki Yamaguchi, Motoi Kikusato, et al.
BMJ Open Diabetes Research & Care|August 13, 2021
Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney diseaseMasayuki Yamanouchi, Kengo Furuichi, Junichi Hoshino, et al.
Pageof 12